Illicit Drug use in the Asia Pacific Region - Burnet Institute
Illicit Drug use in the Asia Pacific Region - Burnet Institute
Illicit Drug use in the Asia Pacific Region - Burnet Institute
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Situational analysis of illicit drug issues and responses <strong>in</strong> <strong>the</strong> <strong>Asia</strong>–<strong>Pacific</strong> region<br />
vi<br />
Acknowledgements<br />
The researchers wish to acknowledge <strong>the</strong><br />
support and cooperation of all of <strong>the</strong> people<br />
who made valuable contributions to our<br />
understand<strong>in</strong>gs of drug <strong>use</strong> and responses <strong>in</strong><br />
<strong>the</strong> countries reviewed . The team is grateful<br />
to all <strong>the</strong> colleagues who reviewed drafts of<br />
<strong>the</strong> country profiles and provided valuable<br />
comments:<br />
<strong>Pacific</strong>: Professor Mac Marshall,<br />
Nic MacClellan, Judith Leveillee, Ruth<br />
Holland, Harley Stanton, Shaun Evans<br />
Cambodia: Graham Shaw<br />
Ch<strong>in</strong>a: Liu Zhim<strong>in</strong><br />
Hong Kong: Yuet Cheung<br />
Indonesia: Elizabeth Pisani<br />
and Elizabeth Emrys<br />
Laos: Damien Hoy<br />
Macao: Celeste Vong<br />
Malaysia: Adeeba bte Kamarulzaman<br />
Myanmar: Willie DeMaere<br />
and Dr Myo Lw<strong>in</strong><br />
Philipp<strong>in</strong>es: Carm<strong>in</strong>a A . Aqu<strong>in</strong>o, M .D .,<br />
Lheng Matibag<br />
Thailand: Nick Thompson<br />
Vietnam: Khuat Thi Hai Oanh, Peter Higgs<br />
and Nick Walsh<br />
The authors would like to acknowledge<br />
<strong>the</strong> advisory roles of Professor Nick Crofts,<br />
Associate Professor Alison Ritter and Dr David<br />
Jacka . The team is also very appreciative of<br />
<strong>the</strong> research assistance provided by Helena<br />
Faulkner .<br />
F<strong>in</strong>ally, <strong>the</strong> support of <strong>the</strong> ANCD’s <strong>Asia</strong>–<br />
<strong>Pacific</strong> <strong>Drug</strong> Issues Committee is s<strong>in</strong>cerely<br />
appreciated .<br />
Executive summary<br />
Context<br />
In October 2003 <strong>the</strong> Prime M<strong>in</strong>ister announced<br />
that <strong>the</strong> Australian National Council on <strong>Drug</strong>s<br />
(ANCD) had been asked to <strong>in</strong>crease Australia’s<br />
<strong>in</strong>volvement throughout <strong>the</strong> <strong>Asia</strong>–<strong>Pacific</strong><br />
region, specifically to promote <strong>the</strong> prevention<br />
and reduction of drug <strong>use</strong>, and treatment<br />
for those with drug problems . To provide<br />
appropriate advice to <strong>the</strong> Australian Government,<br />
<strong>the</strong> ANCD formed a committee of<br />
<strong>in</strong>dividuals with a broad range of experience<br />
and expertise <strong>in</strong> drug policy and <strong>in</strong> <strong>Asia</strong> and<br />
<strong>the</strong> <strong>Pacific</strong> . The mission of <strong>the</strong> <strong>Asia</strong>–<strong>Pacific</strong><br />
<strong>Drug</strong> Issues Committee (APDIC) is to advise<br />
<strong>the</strong> ANCD and <strong>the</strong> Australian Government<br />
on ways to maximise Australia’s response to<br />
and leadership and impact on <strong>Asia</strong>–<strong>Pacific</strong><br />
regional illicit drug issues .<br />
In order to provide a foundation for its work,<br />
<strong>in</strong> November 2004 APDIC contracted <strong>the</strong><br />
<strong>Burnet</strong> <strong>Institute</strong>’s Centre for Harm Reduction<br />
and Turn<strong>in</strong>g Po<strong>in</strong>t Alcohol and <strong>Drug</strong> Centre<br />
to undertake a situational analysis of illicit<br />
drug issues and responses <strong>in</strong> <strong>the</strong> <strong>Asia</strong>–<br />
<strong>Pacific</strong> region .<br />
The project was desk-based; data sources<br />
<strong>in</strong>cluded published and unpublished literature<br />
and <strong>in</strong>formation from key <strong>in</strong>formants<br />
and regional <strong>in</strong>stitutions . For <strong>the</strong> purposes<br />
of this project <strong>the</strong> <strong>Asia</strong>–<strong>Pacific</strong> region was<br />
deemed to <strong>in</strong>clude <strong>the</strong> countries <strong>in</strong>volved <strong>in</strong><br />
<strong>the</strong> ASEAN and Ch<strong>in</strong>a Cooperative Operations<br />
<strong>in</strong> Response to Dangerous <strong>Drug</strong>s (ACCORD),<br />
and those <strong>Pacific</strong> nations of <strong>in</strong>terest to<br />
AusAID . The situational analysis foc<strong>use</strong>d on<br />
<strong>the</strong> unsanctioned <strong>use</strong> of all illicit drugs and<br />
directly related harms, with consideration<br />
of pharmaceutical drugs limited to <strong>the</strong>ir<br />
<strong>in</strong>tentional mis<strong>use</strong> .<br />
The body of this report provides a brief summary<br />
of <strong>the</strong> current illicit drug <strong>use</strong> situation,<br />
country responses to illicit drug issues, and<br />
Australian and <strong>in</strong>ternational <strong>in</strong>volvement<br />
<strong>in</strong> relation to illicit drugs for each country .<br />
More detailed analysis about each country,<br />
complete with referenc<strong>in</strong>g, is conta<strong>in</strong>ed <strong>in</strong><br />
Appendix A; and Australian and <strong>in</strong>ternational<br />
project <strong>in</strong>formation, available at <strong>the</strong> time of<br />
<strong>the</strong> research, is outl<strong>in</strong>ed <strong>in</strong> Appendix B . The<br />
executive summary gives a broad overview<br />
of <strong>the</strong>se data with f<strong>in</strong>d<strong>in</strong>gs for <strong>Asia</strong> and <strong>the</strong><br />
<strong>Pacific</strong> presented separately .<br />
The first th<strong>in</strong>g to note about illicit drug<br />
production and <strong>use</strong> <strong>in</strong> <strong>Asia</strong> is its scale — <strong>the</strong><br />
amount of illicit drugs produced, especially<br />
hero<strong>in</strong> and amphetam<strong>in</strong>e-type substances<br />
(ATS), is measurable <strong>in</strong> many tonnes per year;<br />
numbers of people us<strong>in</strong>g and dependent on<br />
illicit drugs run <strong>in</strong>to <strong>the</strong> millions across <strong>the</strong><br />
region . Issues of such magnitude challenge<br />
<strong>the</strong> capacity of developed nations, let alone<br />
those that are attempt<strong>in</strong>g to hasten social<br />
and economic development, often from<br />
a low base .<br />
Second, <strong>the</strong>re is a profound impact on every<br />
level and sector of society of <strong>the</strong> illicit drug<br />
trade and <strong>use</strong> . Some aspects of this impact<br />
are especially <strong>in</strong>iquitous to <strong>the</strong> atta<strong>in</strong>ment<br />
of development goals, such as corruption,<br />
which are commonly l<strong>in</strong>ked with <strong>the</strong> drug<br />
trade and can be particularly destructive <strong>in</strong><br />
regard to law enforcement .<br />
vii<br />
Executive summary